Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
As of September 2021, 117 COVID-19 vaccines are in clinical development, and 194 are in preclinical development as per the World Health Organization (WHO) published draft landscape. Among the 117 vaccines undergoing clinical trials, the major platforms include protein subunit; RNA; inactivated virus...
Saved in:
Main Authors: | Gaurav Joshi (Author), Pobitra Borah (Author), Shweta Thakur (Author), Praveen Sharma (Author), Mayank (Author), Ramarao Poduri (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
by: Balázs Horváth, et al.
Published: (2022) -
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
by: Maija Radzina, et al.
Published: (2023) -
Where we are, where we are going
by: Teresa Bermejo-Vicedo, et al.
Published: (2020) -
Violence: where do we stand?
by: Wasantha Gunathunga
Published: (2001) -
Phytotherapy for Cachexia: Where Do We Stand?
by: Kenny Kuchta, et al.
Published: (2020)